Advanced Accelerator Applications SA is a radiopharmaceutical company. It develops, produces and commercializes molecular nuclear medicine diagnostic and therapeutic products.
Company profile
Ticker
AAAP
Exchange
Website
CEO
Stefano Buono
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
AAAP stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
12 Feb 18
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 18
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Feb 18
25
Voluntary exchange delisting
1 Feb 18
6-K
Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer
1 Feb 18
SC 14D9/A
Tender offer solicitation (amended)
1 Feb 18
SC TO-T/A
Third party tender offer statement (amended)
1 Feb 18
6-K
Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
26 Jan 18
6-K
Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer
22 Jan 18
SC 14D9/A
Tender offer solicitation (amended)
22 Jan 18
Latest ownership filings
SC 13G/A
Advanced Accelerator Applications S.A.
26 Feb 19
SC 13G/A
Advanced Accelerator Applications S.A.
14 Feb 18
SC 13G/A
Advanced Accelerator Applications S.A.
13 Feb 18
SC 13D
Advanced Accelerator Applications S.A.
1 Feb 18
SC 13G/A
Advanced Accelerator Applications S.A.
30 Jan 18
SC 13G/A
Advanced Accelerator Applications S.A.
30 Jan 18
SC 13G
Advanced Accelerator Applications S.A.
14 Feb 17
SC 13G/A
Advanced Accelerator Applications S.A.
14 Feb 17
SC 13G/A
Advanced Accelerator Applications S.A.
14 Feb 17
SC 13G/A
Advanced Accelerator Applications S.A.
8 Feb 17